API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.nytimes.com/2020/07/01/business/Novartis-kickbacks-diabetes-heart-drugs.html
http://www.pharmatimes.com/news/nhs_england_scraps_7_more_drugs_on_prescription_1293506
https://www.fiercepharma.com/pharma/big-pharma-hits-3b-payments-to-doctors-and-teaching-hospitals-cms
https://www.fiercepharma.com/pharma/court-document-filed-error-reveals-novartis-kickback-suit-settlement-talks-report
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205769
https://www.ema.europa.eu/en/aliskiren-product-specific-bioequivalence-guidance
https://www.ema.europa.eu/documents/product-information/rasilez-hct-epar-product-information_en.pdf
https://www.fiercepharma.com/legal/kickbacks-evidence-against-novartis-wide-ranging-and-comprehensive-feds-say
https://www.biospace.com/article/releases/noden-pharma-announces-fda-approval-of-tekturna-aliskiren-oral-pellets-for-the-treatment-of-hypertension-in-adults-and-children-6-years-of-age-and-older/
http://www.prnewswire.com/news-releases/noden-pharma-notified-of-anda-filing-for-tekturna-300468350.html
http://www.biospace.com/News/new-fda-report-cites-22-drugs-that-passed-phase-ii/444652/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.financialexpress.com/article/industry/companies/novartis-refused-patent-for-anti-hypertension-drug-combination/231853/
http://www.prnewswire.co.uk/news-releases/apac-anti-hypertensive-therapy-market-hit-157-billion-in-2014-and-will-reach-199-billion-by-2021-says-gbi-research-563349381.html